,16,19 Another important target in this region is XPO1 on 2p15, in which the p.E571K activating mutation has been described in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma with a prevalence of 25%.35 The gene discussed is XPO1; the disease is B-cell non-Hodgkin lymphoma.